홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Trifluoroacetic acid → 1-[2-(2-Ethylbenzoimidazol-1-yl)-9-methyl-6-morpholin-4-yl-9H-purin-8-yl]-1-piperidin-4-ylethanol

HRID 1946204
인쇄

반응식

HRID 1946204 반응식
C(OC([N:8]1[CH2:13][CH2:12][CH:11]([C:14]([C:17]2[N:18]([CH3:43])[C:19]3[C:24]([N:25]=2)=[C:23]([N:26]2[CH2:31][CH2:30][O:29][CH2:28][CH2:27]2)[N:22]=[C:21]([N:32]2[C:36]4[CH:37]=[CH:38][CH:39]=[CH:40][C:35]=4[N:34]=[C:33]2[CH2:41][CH3:42])[N:20]=3)([OH:16])[CH3:15])[CH2:10][CH2:9]1)=O)(C)(C)C.C(O)(C(F)(F)F)=O>C(Cl)Cl>[CH2:41]([C:33]1[N:32]([C:21]2[N:20]=[C:19]3[C:24]([N:25]=[C:17]([C:14]([CH:11]4[CH2:12][CH2:13][NH:8][CH2:9][CH2:10]4)([OH:16])[CH3:15])[N:18]3[CH3:43])=[C:23]([N:26]3[CH2:31][CH2:30][O:29][CH2:28][CH2:27]3)[N:22]=2)[C:36]2[CH:37]=[CH:38][CH:39]=[CH:40][C:35]=2[N:34]=1)[CH3:42]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

4

반응물 2

HCID 6422Trifluoroacetic acidHCID 596055744-{1-[2-(2-Ethylbenzoimidazol-1-yl)-9-methyl-6-morpholin-4-yl-9H-purin-8-yl]-1-hydroxyethyl}piperidine-1-carboxylic acid tert-butyl ester

생성물 1

HCID 596055621-[2-(2-Ethylbenzoimidazol-1-yl)-9-methyl-6-morpholin-4-yl-9H-purin-8-yl]-1-piperidin-4-ylethanol

시약·촉매·용매 1

HCID 6344Dichloromethane용매

실험 절차

To a solution of 4-{1-[2-(2-ethylbenzoimidazol-1-yl)-9-methyl-6-morpholin-4-yl-9H-purin-8-yl]-1-hydroxyethyl}piperidine-1-carboxylic acid tert-butyl ester (104 mg, 0.18 mmol) in DCM (1 mL) was added TFA (1 mL) and the resulting mixture stirred for 1 h. The reaction mixture was concentrated in vacuo and azeotroped with DCM affording 1-[2-(2-Ethylbenzoimidazol-1-yl)-9-methyl-6-morpholin-4-yl-9H-purin-8-yl]-1-piperidin-4-ylethanol. LCMS (method A): RT 1.88 min, [M+H]+ 491.2

후처리

  1. concentrationThe reaction mixture was concentrated in vacuo
  2. customazeotroped with DCM

출처 및 근거

ORD 기록
ord-e27ca810f4b8421ca6885b7f3ec2534d
출처 데이터셋
uspto-grants-2013_03
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08394796B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트